Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Megestrol Acetate Plus Metformin in Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma
NCT01968317Phase 2Completed
- Start
- Oct 2013
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in endometrial atypical hyperplasia (AEH), endometrial adenocarcinoma. Started Oct 2013; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
endometrial atypical hyperplasia (AEH)endometrial adenocarcinoma
Beyond the preview
Go deeper on NCT01968317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01968317.